XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses        
Research and development $ 5,423 $ 1,487 $ 11,082 $ 3,951
General and administrative 2,894 1,404 8,809 3,392
Total operating expenses 8,317 2,891 19,891 7,343
Financing expense (income), net (237) 77 27 99
Loss before taxes 8,080 2,968 19,918 7,442
Taxes on income (benefit) 0 0 (544) 0
Net loss for the period $ 8,080 $ 2,968 $ 19,374 $ 7,442
Basic loss per Ordinary Share [1],[2] $ 0.035 $ 0.013 $ 0.085 $ 0.038
Diluted loss per Ordinary Share [1],[2] $ 0.035 $ 0.013 $ 0.085 $ 0.038
Weighted average number of Ordinary Shares outstanding, basic [1],[2] 228,773,418 227,956,060 228,349,115 195,292,384
Weighted average number of Ordinary Shares outstanding, diluted [1],[2] 228,773,418 227,956,060 228,349,115 195,292,384
[1] 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).
[2] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1B).